Mabion S.A. (MAB.WA)
PLN 9.49
(-4.33%)
PLN 9.49
(-4.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 151.67 Million PLN | -7.5% |
| 2022 | 163.98 Million PLN | 188.33% |
| 2021 | 56.87 Million PLN | 0.0% |
| 2020 | - PLN | 0.0% |
| 2019 | - PLN | 0.0% |
| 2018 | - PLN | 0.0% |
| 2017 | - PLN | 0.0% |
| 2016 | - PLN | -100.0% |
| 2015 | 2.73 Million PLN | 229.4% |
| 2014 | 829.7 Thousand PLN | 14205.17% |
| 2013 | 5800.00 PLN | -99.34% |
| 2012 | 884.78 Thousand PLN | -10.21% |
| 2011 | 985.37 Thousand PLN | -35.49% |
| 2010 | 1.52 Million PLN | 0.0% |
| 2009 | - PLN | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 29.77 Million PLN | -12.35% |
| 2024 Q3 | 516 Thousand PLN | -98.27% |
| 2024 Q1 | 33.97 Million PLN | -26.98% |
| 2023 Q3 | 29.57 Million PLN | -17.9% |
| 2023 Q2 | 36.02 Million PLN | -8.89% |
| 2023 FY | 151.67 Million PLN | -7.5% |
| 2023 Q1 | 39.54 Million PLN | -7.92% |
| 2023 Q4 | 46.52 Million PLN | 57.29% |
| 2022 Q3 | 38.48 Million PLN | -12.37% |
| 2022 Q1 | 38.64 Million PLN | -30.11% |
| 2022 FY | 163.98 Million PLN | 188.33% |
| 2022 Q4 | 42.94 Million PLN | 11.61% |
| 2022 Q2 | 43.91 Million PLN | 13.65% |
| 2021 FY | 56.87 Million PLN | 0.0% |
| 2021 Q4 | 55.28 Million PLN | 0.0% |
| 2021 Q1 | - PLN | 0.0% |
| 2021 Q3 | - PLN | -100.0% |
| 2021 Q2 | 1.59 Million PLN | 0.0% |
| 2020 Q1 | - PLN | 0.0% |
| 2020 Q4 | - PLN | 0.0% |
| 2020 FY | - PLN | 0.0% |
| 2020 Q3 | - PLN | 0.0% |
| 2020 Q2 | - PLN | 0.0% |
| 2019 Q4 | - PLN | 0.0% |
| 2019 FY | - PLN | 0.0% |
| 2019 Q1 | - PLN | 0.0% |
| 2019 Q2 | - PLN | 0.0% |
| 2019 Q3 | - PLN | 0.0% |
| 2018 Q1 | - PLN | 0.0% |
| 2018 FY | - PLN | 0.0% |
| 2018 Q3 | - PLN | 0.0% |
| 2018 Q2 | - PLN | 0.0% |
| 2018 Q4 | - PLN | 0.0% |
| 2017 Q4 | - PLN | 0.0% |
| 2017 Q3 | - PLN | 0.0% |
| 2017 Q2 | - PLN | 0.0% |
| 2017 Q1 | - PLN | 0.0% |
| 2017 FY | - PLN | 0.0% |
| 2016 Q2 | - PLN | 0.0% |
| 2016 Q1 | - PLN | -100.0% |
| 2016 FY | - PLN | -100.0% |
| 2016 Q4 | - PLN | 0.0% |
| 2016 Q3 | - PLN | 0.0% |
| 2015 Q1 | 177 Thousand PLN | -24.26% |
| 2015 Q2 | 2.55 Million PLN | 1340.85% |
| 2015 FY | 2.73 Million PLN | 229.4% |
| 2015 Q4 | 6000.00 PLN | 0.0% |
| 2015 Q3 | - PLN | -100.0% |
| 2014 FY | 829.7 Thousand PLN | 14205.17% |
| 2014 Q4 | 233.7 Thousand PLN | 1068.5% |
| 2014 Q3 | 20 Thousand PLN | -90.57% |
| 2014 Q2 | 212 Thousand PLN | -41.76% |
| 2014 Q1 | 364 Thousand PLN | 486.41% |
| 2013 Q1 | 471 Thousand PLN | 116.27% |
| 2013 Q3 | - PLN | 100.0% |
| 2013 Q4 | -94.2 Thousand PLN | 0.0% |
| 2013 Q2 | -371 Thousand PLN | -178.77% |
| 2013 FY | 5800.00 PLN | -99.34% |
| 2012 Q2 | 7000.00 PLN | -97.89% |
| 2012 Q4 | 217.78 Thousand PLN | -33.6% |
| 2012 FY | 884.78 Thousand PLN | -10.21% |
| 2012 Q1 | 332 Thousand PLN | 0.0% |
| 2012 Q3 | 328 Thousand PLN | 4585.71% |
| 2011 FY | 985.37 Thousand PLN | -35.49% |
| 2010 FY | 1.52 Million PLN | 0.0% |
| 2009 FY | - PLN | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bioceltix S.A. | - PLN | -Infinity% |
| BIOTON S.A. | 181.63 Million PLN | 16.493% |
| Captor Therapeutics Spolka Akcyjna | 13.2 Million PLN | -1048.989% |
| Molecure S.A. | 100.00 PLN | -151677900.0% |
| NanoGroup S.A. | 2019.00 PLN | -7512430.956% |
| Pharmena S.A. | 9.83 Million PLN | -1441.913% |
| Poltreg S.A. | 1.39 Million PLN | -10741.887% |
| Pure Biologics Spólka Akcyjna | 95 Thousand PLN | -159561.053% |
| Ryvu Therapeutics S.A. | 46.86 Million PLN | -223.683% |
| Synthaverse S.A. | 58.6 Million PLN | -158.805% |
| Urteste S.A. | - PLN | -Infinity% |